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ABSTRACT: Genital epithelial tumors of Atlantic bottlenose dolphins (Tursiops truncatus [Tt]) and
Burmeister’s porpoises (Phocoena spinipinnis) were formerly shown to be associated with
papillomavirus (PV) infection. Papillomaviruses are highly prevalent viruses involved in the
development of various tumor types in a wide range of animals, and so-called high-risk PVs
contribute to malignant progression. In marine mammals, the incidence and prevalence of PV
infection, transmission pathways, and persistence of infection are largely unknown. Using virus-
like particles of bottlenose dolphin PV type 1 (TtPV1) as the antigen, enzyme-linked
immunosorbent assay (ELISA) studies were conducted to evaluate PV antibody prevalence in
bottlenose dolphins. In total, sera obtained from 115 dolphins were examined. Fifty-one percent of
captive dolphins (n518 of 35) and 90% of free-ranging dolphins (n572 of 80) were antibody
positive. Higher ELISA reactivity was observed among males compared with females. Sexually
immature dolphins appeared more likely to seroconvert with age. Besides determining their PV
antibody prevalence, each animal was also assessed for the presence of orogenital tumors.
Interestingly, the mean age of free-ranging dolphins with tumors (n521) was 11.2 yr compared
with 29.9 yr in captive dolphins with tumors (n59). Results from the current study suggest PV
infection in bottlenose dolphins is common, that the main route of PV transmission among them
may be horizontal, and that orogenital neoplasia may develop in early life stages of certain free-
ranging bottlenose dolphins.
Key words: Antibodies, bottlenose dolphin, infectious disease, neoplasia, papillomavirus,
serology, TtPV, tumors, Tursiops truncatus.
INTRODUCTION
Papillomaviruses (PVs) are widely dis-
tributed infectious agents in humans and
animals. By interfering with tumor-sup-
pressor pathways of host proteins, PVs are
able to induce a hyperproliferation of
suprabasal epithelial cells (Chow and
Broker, 1994). Depending on the immune
status of the specific host and cofactors
(i.e., smoking, X-rays, ultraviolet light, diet,
or concurrent infections with other agents),
benign cutaneous or mucosal tumors pri-
marily associated with high-risk PV types
can undergo malignant progression.
Papillomavirus infection is a necessary
cause of invasive cervical carcinoma (Wal-
boomers et al., 1999), the second most
frequent cancer of women worldwide
(Einstein and Goldberg, 2002). Because
human PVs (HPVs) are the most frequent-
ly sexually transmitted viruses (Garland,
2002), transmission pathways and disease
incidence are of growing concern in
animals as well. More than 50 nonhuman,
species-specific, distinct PVs have been
described to date, and novel types are
constantly being detected in epithelial
tumors from many vertebrates, including
domestic species and wild animals.
A high prevalence of orogenital papillo-
mas in free-ranging porpoises and dol-
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phins has been documented (Van Bressem
et al., 1996; Bossart et al., 2005). Recently,
squamous cell carcinoma, suggestive of
malignant transformation of benign papil-
lomatous lesions, was described in a
captive dolphin (Bossart et al., 2005).
Subsequently, four mucosotropic, spe-
cies-specific, cetacean PVs have been
completely characterized: Atlantic bottle-
nose dolphin PV types 1, 2, and 3
[Tursiops truncatus PVs (TtPV1, -2,
-3); EU240894, NC_008184, EU240895;
Rehtanz et al., 2006; Rector et al., 2008) as
well as the Burmeister’s porpoise PV type
1 [Phocoena spinipinnis PV (PsPV1);
NC_003348], with a second PsPV type
potentially existing (Van Bressem et al.,
2007). Among these viruses, TtPV2 may
represent a high-risk type based on DNA
sequence investigations (Rehtanz et al.,
2006). Although the association of these
PVs with mucosal tumors was demonstrat-
ed in all cases and such tumors seem to be
highly prevalent in at least two cetacean
species, nothing is known about PV
prevalence in marine mammals. Despite
the existence of more than 50 nonhuman
PVs, transmission pathways in animals
have not been investigated thoroughly,
and the extent and distribution of PV
infection in marine mammals has not been
established.
The humoral response to HPV is
directed predominantly to native confor-
mational epitopes on the whole virion
(Steele and Gallimore, 1990). Immuno-
logic studies of PV infection have been
impeded by the lack of a cell culture
system for PVs and, thus, the absence of
adequate targets for serologic assays. The
recent use of virus-like particles (VLPs) as
antigenic targets has addressed this prob-
lem (Cubie et al., 1998). These VLPs
consist of the major capsid protein L1 of
the respective PV type. When expressed in
an appropriate eukaryotic cell system, L1
self-assembles into PV VLPs that demon-
strate conformational epitopes.
To shed light on PV prevalence and
transmission patterns in bottlenose dol-
phins, VLPs of TtPV1 and TtPV2 were
developed for serologic screening and the
validity of the corresponding test was
investigated and confirmed (Rehtanz et
al., 2009). In pilot studies, bottlenose
dolphin sera reacted positively or nega-
tively, respectively, in both the TtPV1 and
TtPV2 enzyme-linked immunosorbent as-
say (ELISA), indicating cross-reactivity
between the two VLP types. The TtPV1
VLPs were subsequently chosen as the
antigen for the test, based on higher yields
of type 1 VLPs after protein expression
and particle purification (Rehtanz et al.,
2009). Herein, we report the use of the
TtPV1 ELISA test for determination of PV
antibody prevalence in four groups of
bottlenose dolphins and corresponding
statistical analyses.
MATERIALS AND METHODS
Dolphin populations sampled
Bottlenose dolphin sera (n5119, from 115
animals) were obtained from two free-ranging
populations (n580) and two captive groups
(n535). Sera from free-ranging dolphins were
obtained from the Atlantic Bottlenose Dolphin
Health and Risk Assessment (HERA) Project, a
collaborative effort between Harbor Branch
Oceanographic Institution (HBOI), and the
National Oceanic and Atmospheric Adminis-
tration (NOAA). Dolphins were captured,
examined and released in the Indian River
Lagoon (IRL), Florida, USA, in June of 2004,
2005, and 2006 (n551), and in the estuarine
waters near Charleston (CHS), South Carolina,
USA, in August of 2004 and 2005 (n529).
Captive dolphins were sampled in 2005 and
2006 in Sea Life Park (SLP) by Dolphin
Discovery in Waimanalo, Hawaii, USA
(n522), and in 2001 and 2002 in the Mundo
Aqua´tico Zoomarine (MAZ) in Albufeira, Por-
tugal (n513). Dolphins studied were Atlantic
bottlenose dolphins (Tursiops truncatus) with
the exception of two Pacific bottlenose dolphins
(Tursiops truncatus gilli; SLP).
Ages of free-ranging dolphins were deter-
mined by tooth examination according to
Hohn and colleagues (1989). Ages of captive
dolphins were estimated by veterinarians from
the overall condition of the animals and their
total body length according to Geraci and
Lounsbury (2005). Sexual maturity was deter-
mined according to Odell (1975) and Mead
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and Potter (1990). Females were considered
sexually mature when they had reached
,2.3 m in length, at about 5 to 12 yr, males,
when they had reached ,2.4 to 2.6 m,
typically between their 10th and 12th yr. All
dolphins were also physically examined for the
presence of oral and/or genital tumors.
PV antibody prevalence ELISA studies
The determination of antibody reactivity to
TtPV1 VLPs was carried out as previously
described (Rehtanz et al., 2009). Briefly,
incubations were performed at 37 C for 1 hr
with three to five intermediate phosphate-
buffered saline (PBS) washing steps. Sera and
antibodies were diluted in PBS/1% bovine
serum albumin (BSA). The ELISA microplates
(Dynatech Laboratories, Inc., Chantilly, Virgin-
ia, USA) were coated with 50 ng of intact VLPs
in PBS, followed by blocking with 5% BSA. The
coated VLPs were incubated with dolphin sera
diluted 1:300, followed by rabbit anti-dolphin
immunoglobulin G, diluted 1:3,000, and alka-
line phosphatase-coupled goat anti-rabbit anti-
body, diluted 1:5,000 (Sigma, St. Louis, Mis-
souri, USA). The reactivities were measured at
405 nm (Spectra MRTM, Dynex Technologies,
Chantilly, Virginia, USA) using 1041 p-nitro-
phenyl phosphate (Sigma).
One dolphin (CHS) with a TtPV1 ELISA
mean absorbance of 0.128 represented the
positive control animal. At the time of serum
collection, this dolphin had an active genital
tumor, which was subsequently diagnosed as
being TtPV2-associated (Rehtanz et al., 2006).
Serum from this dolphin showed a similar
mean absorbance of 0.141 in the TtPV2
ELISA. A disease-free, 4-mo-old, dolphin calf
(SLP) served as the negative control (Rehtanz
et al., 2009). The seropositive cutoff value was
defined as an absorbance of 0.1 after back-
ground subtraction, representing a minimum
twofold standard deviation (Rehtanz et al.,
2009).
Three dolphins were sampled more than
once. One of those (CHS) was sampled before
and after the health assessment to verify that
the examination had no effect on the PV
antibody prevalence result. Another animal
(SLP) was sampled monthly for three consec-
utive months, whereas a third dolphin (MAZ)
was sampled twice at a 7-mo interval to
monitor possible short-term changes in the
ELISA reactivity.
Statistical analyses
Geometric means were compared between
sample groups unless otherwise stated. Four
sera resulting from repeated sampling of three
of the 115 dolphins were not included in the
analyses to preserve sample independence. F
tests were performed to determine whether
sample variances were statistically different,
whereas two-sided t tests were performed to
compare sample reactivities. P values are
reported for either equal or unequal variances
based on the results of the F test. Statistical
significance was defined as P,0.05. Chi-
square tests were used to compare the
prevalence of PV antibody across population
groups. Yates’ correction was applied when the
expected frequency in any cell was ,5.
Fisher’s exact test was used when a cell
contained a frequency of ,5. In preliminary
analyses, males were found to be older, on
average, in both captive and free-ranging
populations (P50.048 and P50.095, respec-
tively). Therefore, the seroprevalence data
were adjusted for age in logistic regression
(SAS software, version 9.1, SAS Institute, Inc.,
Cary, North Carolina, USA).
Animal use
The acquisition of serum from captive
dolphins for the current study complied with
all relevant federal guidelines and institutional
policies; sera from free-ranging dolphins were
collected under National Marine Fisheries
Service Scientific Research Permit 998-1678
issued to Gregory D. Bossart.
RESULTS
PV seroprevalence and analysis of ELISA reactivity
Sera from 115 dolphins representing
four different groups were investigated.
The prevalence of anti-PV antibodies in
bottlenose dolphins was high across the
population groups. Antibody prevalence
was significantly (P,0.001) higher in free-
ranging dolphins (72 of 80; 90%) com-
pared with captive dolphins (18 of 35;
51%). Dolphins in the IRL were more
likely to be seropositive (48 of 51; 94%)
than dolphins in CHS (24 of 29; 83%), but
the difference was not statistically signif-
icant. Fifty-nine percent of the dolphins
tested from the SLP had anti-PV antibod-
ies (13 of 22), whereas 38% of the sera
obtained from dolphins maintained in the
MAZ showed reactivity in the assays (5 of
13); this difference was also not statisti-
cally significant.
The magnitude of ELISA reactivity
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against PV was also analyzed. The overall
mean reactivity was 0.179, the highest
absorbance, 0.83, and the lowest, 0.015.
Free-ranging dolphins generally had high-
er ELISA values than captive animals. The
mean of the ELISA absorbance for all
free-ranging dolphins was 0.176, whereas
that of all captive animals was 0.103
(P50.0017). Dolphins from the IRL pop-
ulation had significantly higher reactivity
when compared with CHS animals with
mean ELISA values of 0.197 and 0.144,
respectively (P50.0028).
One of the three seronegative dolphins
from the IRL and all seronegative animals
from CHS were sexually immature. Like-
wise, all sexually immature captive dol-
phins were seronegative. There were no
age-related significant differences in PV
seropositivity among all sexually mature
dolphins (P.0.05). However, among all
sexually immature dolphins, including
males up to 10 yr and females up to 5 yr,
the youngest dolphins of all groups were
seronegative, and seropositivity increased
with increasing age (Fig. 1A). Within this
group of sexually immature animals, the
mean PV ELISA absorbance for those
between 0 and 5 yr (n518) was 0.092,
whereas that of dolphins older than 5 yr,
but younger than 10 yr (n515), was 0.208
(P50.0108). Ten of 14 (71%) offspring of
captive dams were seronegative, whereas
the four seropositive dolphins were no
longer sexually immature when tested.
Among the captive offspring, all sexually
immature dolphins (n56) were seronega-
tive, regardless of the status of their
parents. These data suggest vertical trans-
mission does not commonly occur and that
the main route of PV transmission among
bottlenose dolphins may be horizontal.
Eight of nine seronegative animals
(89%) from the SLP were born in
captivity, whereas four of eight (50%) of
those testing negative from the MAZ were
born in captivity.
No significant differences in antibody
prevalence were found between males and
females among free-ranging dolphins
(89% and 91%, respectively), but among
captive dolphins, males were more likely
to be seropositive than females (77%
versus 28%, P50.01). Concerning ELISA
value magnitude, male dolphin sera ex-
hibited higher reactivity than sera from
females (Fig. 1B). The means for males
(n564) and females (n551) were 0.184
and 0.115, respectively (P,0.0001). With
the exception of one female, all values
above 0.3 were obtained from males
(n511). To determine the statistical influ-
ence of these higher values among males,
FIGURE 1. Gender and age in correlation with
papillomavirus enzyme-linked immunosorbent assay
(ELISA) reactivity in bottlenose dolphins. (A) A
correlation of age with ELISA reactivity was noticed
among sexually immature dolphins with an increasing
reactivity mean in the papillomavirus (PV) ELISA
with increasing age. Statistical significance was noted
investigating sexually immature dolphins by compar-
ing animals up to 5 yr of age with dolphins between
5 yr and 10 yr of age (P50.0108). (B) Females and
male dolphins are listed from lowest to highest
ELISA value on the x-axis. Males had slightly higher
values compared with females (P,0.0001).
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the analyses were repeated excluding all
animals with ELISA reactivity above 0.3.
The difference between males (n553; 15
captive, 38 free-ranging) and females
(n550; 17 captive, 33 free-ranging) re-
mained statistically significant (P50.0011).
Orogenital papillomas and ELISA reactivity
A physical examination revealed that 21
of the free-ranging dolphins tested by
ELISA (26%) had one or more genital or
oral tumors. The TtPV2 was detected in a
biopsy of the genital lesion from one
dolphin (Rehtanz et al., 2006). Another
dolphin had the highest ELISA reactivity
with an absorbance of 0.83 and displayed
an unusual bilateral tongue lesion (Bossart
et al., 2005). Among captive dolphins, nine
of 35 (26%) had a history of recurring oral
and/or genital tumors after cryo-treatment.
These lesions are currently being investi-
gated to determine a possible causative
agent. Of the 30 dolphins with orogenital
neoplasia, 25 (83%) were seropositive in
the PV ELISA, whereas two of the
seronegative dolphins had values very close
to the seropositive cutoff (0.092 and 0.096).
No significant correlation between ELISA
absorbance magnitude and the presence of
an orogenital tumor was seen.
Age was determined for 67 of the 80
free-ranging dolphins (84%) tested (in-
cluding all 21 with tumors) and for all
captive animals. Mean, median, and range
for age are shown in Table 1 for free-
ranging versus captive dolphins and for
dolphins with and without tumors. Mean
and median ages of captive animals were
approximately twice as high as those for
free-ranging animals were. There was no
significant difference in age between free-
ranging dolphins with or without tumors
(mean ages: 11.2 yr versus 10.5 yr). How-
ever, the mean and median ages of captive
dolphins with or without tumors differed.
Captive dolphins with tumors (n59) were
significantly older (mean age: 29.9 yr)
than captive dolphins without tumors
(n526; mean age: 17.9 yr; P50.017).
Approximately 78% of the captive dol-
phins with tumors were older than the
oldest free-ranging dolphins with tumors
(Fig. 2A; P50.0009), whereas only 15% of
captive dolphins without tumors were
older than the oldest free-ranging dol-
phins without tumors (Fig. 2B; P50.01).
These findings indicate that orogenital
tumors may develop in early life stages in
certain free-ranging dolphins.
DISCUSSION
Papillomavirus prevalence as well as
transmission rates and pathways in ceta-
ceans are currently unknown. In this first
PV antibody prevalence study in marine
mammals, some sera showed a low posi-
tive reactivity in the screening. After
having immunized beagles in a dog-VLP
vaccination study, a decrease of serum
ELISA reactivity was observed a few
weeks after challenge when no adjuvant
was used, as opposed to an immunization
with adjuvant (Suzich et al., 1995). This
decrease may also occur in natural infec-
tion because low antibody titers against PV
in positive individuals are not unusual
(Shah and Howley, 1996). In the present
TABLE 1. Median, mean, and range for age of free-ranging versus captive dolphins with and without
orogenital neoplasia (OGN).
Environment Dolphins n Median age Mean age Age range
Free-ranging No OGN 47 8.6 10.5 2.5–28
With OGN 21 9.0 11.2 5–24
Total 68 8.8 10.7 2.5–28
Captive No OGN 26 15.5 17.9 0.3–47
With OGN 9 36.0 29.9 10–39
Total 35 21.0 20.9 0.3–47
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study with dolphins, some ELISA values
were near the seropositive cutoff. For
diagnostic purposes, values near this
cutoff might be considered an appropri-
ate, ‘‘indeterminate’’ reading. Future lon-
gitudinal measurements of ELISA reac-
tivity will elucidate whether values slightly
below the cutoff may represent early
seroconversion from a very recent PV
infection or recent clearance of infection.
Bottlenose dolphins live in fission-fu-
sion societies, in which individuals travel
in small groups that often change in
composition with bonds developing ac-
cording to their present social context.
Variation in social strategies within and
between populations is common (Connor
et al., 2000). Wandering individuals do not
appear to live in stable groups and
disperse from their natal group to join
others for certain activities, including
migration, feeding, and breeding (Connor,
2000). This behavior supports genetic
diversity but, at the same time, facilitates
pathogen transmission. Intense play and
sexual activities both heterosexual and
homosexual, including oral sex (Bagemihl,
2000), may account for a generally high
PV antibody prevalence among dolphins.
The observed ELISA reactivity across
population groups suggests PV infection
has generally been established in bottle-
nose dolphins. Antibody prevalence was
higher among free-ranging than among
captive dolphins. One explanation could
be housing practices and/or the limited
number of available mating partners for
captive dolphins resulting in a lower
probability of horizontal transmission.
This hypothesis is supported by 89% of
seronegative SLP dolphins being born in
captivity. Conversely, half of the seroneg-
ative MAZ dolphins were born in captivity.
The difference between facilities may be
related to time of capture of the respective
animal before horizontal transmission
could take place and/or differences in
housing organization.
Although horizontal transmission of
HPVs infecting the genital mucosa is
well-recognized, nonsexual transmission
remains controversial. In humans, vertical
PV transmission from mother to infant has
not been investigated extensively. Some
studies revealed evidence for vertical
spread (Cason et al., 1995; Rice et al.,
1999), whereas it was considered a rare
event in other studies (Watts et al., 1998).
Maternal viral load may be an important
determinant for vertical transmission be-
cause mothers who transmitted HPV to
their infants had significantly higher viral
loads (Kaye et al., 1994). Data from a
recent comprehensive report testing 100
mothers and their 111 children for HPV
FIGURE 2. Age in correlation with orogenital
neoplasia presence. Free-ranging dolphins with
tumors were younger than captive dolphins with
tumors. Dolphins are listed youngest to oldest, per
group, on the x-axis. (A) Seventy-eight percent of the
captive dolphins with tumors were older than the
oldest free-ranging dolphins with tumors
(P50.0009), whereas only 15% of captive dolphins
without tumors were older than the oldest free-
ranging dolphins without tumors (P50.01) (B).
Orogenital neoplasia (OGN).
REHTANZ ET AL.—PAPILLOMAVIRUS ANTIBODIES IN BOTTLENOSE DOLPHINS 141
infection failed to find evidence for
mother to child transmission (Marais et
al., 2007). All seronegative dolphins from
CHS were sexually immature, which may
indicate transmission among bottlenose
dolphins most often occurs horizontally
and that young dolphins are less likely to
have PV antibody reactivity. This assertion
is supported by all sexually immature
captive dolphins being negative regardless
of their parents’ statuses. Furthermore,
sexually immature dolphins were more
likely to be seropositive with increasing
age. This may be attributed to the onset of
sexual behavior before sexual maturity
(Booth, 1988). Thus, older sexually imma-
ture dolphins have had increased oppor-
tunities to become infected through be-
ginning sexual play and other social
activities than younger sexually immature
dolphins. The seropositive captive off-
spring (n54) may have become infected
after birth, because these dolphins were
already sexually mature when tested.
Slightly higher PV reactivity was ob-
served with serum of males compared
with females. Genital mucosa surface sizes
are approximately the same, which sug-
gests that a larger mucosal area of possible
exposure to viruses in males does not seem
to be involved. The lives of male bot-
tlenose dolphins in particular are charac-
terized by bisexuality with frequent en-
gagements in homosexual relationships
(Bagemihl, 2000). As they exhibit very
active sexual behaviors and play patterns
with females and other males, higher
exposure rates are plausible and may
result in higher levels of humoral re-
sponse.
In total, 30 of the 115 tested dolphins
had a history of orogenital tumors. Five of
these were seronegative in the PV screen-
ing, whereas two of those five had ELISA
reactivities close to the seropositive cutoff.
The observed tumors could be associated
with a PV covered in the test as shown for
the positive control animal (Rehtanz et al.,
2006), but some of the tumors may also be
associated with another unknown dolphin
PV not detected in the test or with another
agent. On the other hand, some dolphins
with tumors may have a weaker immune
response to PV, resulting in low ELISA
reactivity. In some cases, tumor develop-
ment may also be the result of a low
humoral response. In humans, VLPs used
for immunization elicit antibody responses
14 to 40 times higher than those occurring
during a natural infection, where they are
often low (Ault et al., 2004; Fife et al.,
2004; Harper et al., 2006). Papillomavirus
infection seems to be highly prevalent in
dolphins, as is the case in humans, and is
not necessarily associated with clinically
apparent disease in either species. The
natural history of tumor progression or
remission has not been established for
cetaceans in the wild. Screening dolphins
for antibodies will help to determine
whether specific levels of anti-PV antibod-
ies are protective against the development
of tumors and which animals may be at
greater risk.
Interestingly, whereas captive dolphins
with tumors (26%) were mostly older
animals, many of the free-ranging dol-
phins displaying tumors (26%) were con-
siderably younger. The fact that the free-
ranging dolphins assessed for health were,
on average, younger than the dolphins
tested from facilities does not affect the
observation that orogenital tumors devel-
oped in earlier stages of life in both free-
ranging dolphin populations investigated.
In the present study, it was demonstrated
that, among the populations tested, free-
ranging dolphins not only had a signifi-
cantly higher PV antibody prevalence but
also had a magnitude of reactivity in the
ELISA that was higher. This may be
explained by their higher rates of exposure
to one or more TtPVs through their active
sexual lives and likely greater numbers of
mating partners. Furthermore, being
slowly reproducing, top-level predators,
dolphins are sensitive to environmental
disturbances. A number of marine mam-
mal studies have recently documented
that emerging or resurging infectious and
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neoplastic diseases may reflect environ-
mental distress (Bossart, 2006). Negative
immunomodulatory effects of environ-
mental contaminants, such as organochlo-
rines and toxic heavy metals, have been
described in several marine mammal
species (De Guise et al., 1995; Beineke
et al., 2005; Hammond et al., 2005; Levin
et al., 2005; Kannan et al., 2006; Mori et
al., 2006). Whether such environmental
contaminants could have a similar effect
on local free-ranging bottlenose dolphin
populations remains to be investigated.
The analysis described here contributes
to a greater understanding of the epide-
miology of PV infection in marine mam-
mals. In the future, repeated sampling will
be necessary to elucidate transmission
pathways and determine seroconversion
and incidence rates. Research addressing
other infectious agents in tumors, as well
as fundamental research investigating cell-
transforming capabilities of TtPVs, is
needed to determine whether infection
with PV is causal and whether PV acts
alone or in conjunction with other agents.
The potential for TtPVs to cause malig-
nant transformation of benign tumors also
remains to be investigated, as do other
health risks possibly imposed by TtPV
infection.
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